Subsets with reactivation of dysfunctional CD8+, memory-like CD8+TCF7+, CD103+ tumor-resident CD8+, and Tcf1+PD-1+ CD8+ with stem-like properties T cells have shown durable responses. This evidence concerns the gene TCF7 and neoplasm.